This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Eleusis Therapeutics US, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Mark Alan Moran: Innovator in Ketamine Treatment
Introduction
Mark Alan Moran is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of medical treatment, particularly in addressing depression and pain management. His innovative approach has the potential to change the way these conditions are treated.
Latest Patents
Mark Alan Moran holds a patent for a method of treatment involving ketamine infusion. This patent, titled "Method of treatment for ketamine infusion," outlines a process that includes the administration of an antiemetic agent, preferably ondansetron, followed by a synergistic combination of ketamine and a benzodiazepine, preferably lorazepam. This method aims to alleviate symptoms of depression and pain while potentially reducing the need for other medications. He has 1 patent to his name.
Career Highlights
Moran's career is marked by his dedication to improving patient outcomes through innovative treatment methods. His work at Eleusis Therapeutics Us, Inc. has positioned him at the forefront of research in this area. His focus on ketamine infusion therapy reflects a commitment to exploring new avenues for patient care.
Collaborations
Mark has collaborated with notable colleagues, including John Bryan Clifton and J Cannon Clifton. These partnerships have likely contributed to the development and refinement of his innovative treatment methods.
Conclusion
Mark Alan Moran's contributions to the field of medical treatment, particularly through his patent on ketamine infusion, highlight his role as an innovator in addressing complex health issues. His work continues to pave the way for advancements in the treatment of depression and pain management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile